
Hartford Multifactor Developed Markets (ex-US) ETF
Hartford Multifactor Developed Markets (ex-US) ETF (RODM) Price & Chart
RODM ETF Chart & Stats
- Day’s Range
- $40.81 - $41.23
- 52-Week Range
- $35.13 - $42.75
- Previous Close
- $41.52
- Volume
- 154.14K
- Average Volume (3M)
- 89.70K
- AUM
- 1.67B
- NAV
- 40.93
- Expense Ratio
- 0.29%
- Holdings Count
- 324
- Beta
- 0.46
- Inception Date
- Feb 25, 2015
- Last Dividend Ex-Date
- Jun 25, 2026
- Dividend Yield
- (2.83%)
- Shares Outstanding
- 40,200,000
- Standard Deviation
- N/A
ETF Overview
Hartford Multifactor Developed Markets (ex-US) ETF
The Hartford Multifactor Developed Markets (ex-US) ETF (ticker: RODM) is a dynamic investment vehicle designed to offer exposure to developed markets outside of the United States. This exchange-traded fund (ETF) is meticulously crafted for investors seeking to tap into the broad opportunities within international equity markets. RODM strategically focuses on the total market, characterized by its size and style emphasis, making it an ideal choice for those looking to diversify their portfolios with a comprehensive blend of large, mid, and small-cap stocks. RODM stands out in the broad-based niche due to its multifactor approach, which integrates various quantitative techniques to enhance potential returns while managing risk. This multifactor strategy allows the ETF to sift through developed market stocks by assessing key factors such as value, momentum, and quality, ensuring a robust selection process that seeks to optimize performance across diverse economic environments. As a Size and Style focused fund, RODM is committed to capturing the full spectrum of market opportunities by balancing growth potential with stability. It provides exposure to a wide array of industries and sectors, ensuring that investors benefit from a well-rounded investment portfolio. This makes RODM an attractive option for investors aiming to achieve a balanced international equity exposure while leveraging the strategic insights of Hartford's multifactor methodology. In summary, the Hartford Multifactor Developed Markets (ex-US) ETF offers a sophisticated investment solution for those looking to engage with international markets. Its unique focus on total market size and style, combined with a multifactor approach, delivers a compelling blend of growth and risk management tailored to meet the needs of discerning investors.
- Asset Class
- Equity
- Region
- Developed Markets
- Issuer
- Hartford
- Index Tracked
- Hartford Risk-Optimized Multi Developed Markets Ex-US Index
- Ticker Symbol
- RODM
RODM ETF News



GlaxoSmithKline ($GSK) announced an update on their ongoing clinical study. Study Overview: GlaxoSmithKline’s study, officially titled “Long-term Safety and Tolerability Study of Linerixibat for the Treatment of Cholestatic Pruritus in

GlaxoSmithKline ($GSK) announced an update on their ongoing clinical study. Study Overview: GSK’s Phase 3 study, officially titled “A 52-week, Randomized, Double-blind, Double-dummy, Parallel-group, Multi-centre, Non-inferiority Study to Investigate the


GlaxoSmithKline ($GSK) announced an update on their ongoing clinical study. Study Overview: GlaxoSmithKline’s (GSK) official study, “ALARMONY: A Phase 2 Randomized, Double Blind, Placebo Controlled Multi-center Study to Assess the
RODM ETF FAQ
What was RODM’s price range in the past 12 months?
What is the AUM of RODM?
Is RODM overvalued?
Does RODM pay dividends?
How many shares outstanding does RODM have?
Top 10 Holdings
| Name | Weight % |
|---|---|
| 4503Astellas Pharma | 1.04% |
| ROPRoche Holding | 1.04% |
| ERIC.BTelefonaktiebolaget LM Ericsson Class B | 1.02% |
| A5GIE:A5G | 1.01% |
| TTETotalEnergies SE | 1.00% |
| NOVNNovartis | 0.99% |
| GSKGlaxoSmithKline | 0.92% |
| EQNRNO:EQNR | 0.90% |
| FFHFairfax Financial Holdings Ltd | 0.90% |
| 4578Otsuka Holdings Co | 0.89% |
| Total | 9.71% |






